The Most Concerning Long-Term Risks of GLP-1 Drugs Below are the strongest areas of concern based on clinical observations, case reports, patient outcomes, and developing research
pick whichever one matches the question you came in with
WEIGHTWATCHERS CEO SIMA SISTANI OUT IN ABRUPT EXIT, EMBRACED WEIGHT LOSS DRUGS McGowan agreed that patients will need to seek alternative treatments, though he said "it's worth noting that this has never been a viable long-term solution, knowing that supply lines for semaglutide and tirzepatide would eventually be restored." Patients who may lose access can look into options including switching to the brand-name, Zepbound, changing medication class entirely or seeking a procedural or surgical option if that fits their overall goals, according to McGowan
and CapEx revivals in real estate and industrials, especially defense and electrification
Females and Males of Reproductive Potential Discontinue RYBELSUS or OZEMPIC tablets at least 2 months before a planned pregnancy due to the long washout period for semaglutide [see Use in Specific Populations (8.3)]
Recognizing high-risk individuals is crucial for prevention and informed medication use
